John Matthews
About
John Matthews is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, John Matthews has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiation and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John Matthews's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Advanced Radiotherapy Techniques (9 papers). John Matthews is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and Advanced Radiotherapy Techniques (9 papers). John Matthews collaborates with scholars based in Australia, New Zealand and United States. John Matthews's co-authors include Nigel Spry, David Joseph, James W. Denham, Chris Atkinson, Sandra Turner, David Christie, David S. Lamb, Allison Steigler, Keen‐Hun Tai and Catherine D’Este and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.
In The Last Decade
John Matthews
24 papers receiving 1.0k citations
Hit Papers
Peers
John Matthews
Sharon Salenius United States
Keen‐Hun Tai Australia
David S. Lamb New Zealand
Michelle H. Braccioforte United States
Allison Steigler Australia
Phillip Rubin United States
Chris Atkinson New Zealand
S. Guérif France
Friedl Vanhaverbeke Belgium
Julie Butters Australia
Citations per year, relative to John Matthews John Matthews (= 1×)
peers
Sharon Salenius
Countries citing papers authored by John Matthews
Since
Specialization
Citations
This map shows the geographic impact of John Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Matthews more than expected).
Fields of papers citing papers by John Matthews
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by John Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Matthews. The network helps show where John Matthews may publish in the future.
Co-authorship network of co-authors of John Matthews
This figure shows the co-authorship network connecting the top 25 collaborators of John Matthews. A scholar is included among the top collaborators of John Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Matthews. John Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Delahunt, Brett, Allison Steigler, Callum Atkinson, et al.. (2021). Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. Pathology. 54(1). 49–54.
2.
Denham, James W., David Joseph, David S. Lamb, et al.. (2018). Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial. The Lancet Oncology. 20(2). 267–281.
3.
Graham, Mary V., James A. Purdy, Bahman Emami, William B. Harms, & John Matthews. (2015). 3-D Conformal Radiotherapy for Lung Cancer. Frontiers of radiation therapy and oncology. 29. 188–198.
4.
Matthews, John, et al.. (2014). Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report. International Medical Case Reports Journal. 7. 27–27.
5.
Denham, James W., David Joseph, David S. Lamb, et al.. (2014). Main oncologic endpoints of the TROG 03.04 (RADAR) Trial for men with locally advanced prostate cancer. Journal of Clinical Oncology. 32(15_suppl). 5004–5004.
6.
Denham, James W., David Joseph, David S. Lamb, et al.. (2014). Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial. The Lancet Oncology. 15(10). 1076–1089.
7.
Pearse, Maria, Carol Fraser‐Browne, Ian D. Davis, et al.. (2014). A P hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy – Adjuvant Versus Early Salvage ( RAVES ) trial. British Journal of Urology. 113(S2). 7–12.
8.
Denham, James W., Allison Steigler, Keen‐Hun Tai, et al.. (2013). Paradoxical metastatic progression following 3months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer. Radiotherapy and Oncology. 107(2). 123–128.
9.
Denham, James W., David Joseph, Nigel Spry, et al.. (2012). Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. The Lancet Oncology. 13(12). 1260–1270.
10.
Denham, James W., David S. Lamb, Nigel Spry, et al.. (2012). Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer. Radiotherapy and Oncology. 105(2). 184–192.
11.
Pearse, Maria, Andrew Kneebone, Gillian Duchesne, et al.. (2012). What is optimal timing of post prostatectomy radiotherapy? Is adjuvant radiotherapy equivalent to early salvage radiotherapy? The “RAVES” phase III randomized clinical trial.. Journal of Clinical Oncology. 30(15_suppl). TPS4690–TPS4690.
12.
Denham, James W., Allison Steigler, David S. Lamb, et al.. (2011). Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. The Lancet Oncology. 12(5). 451–459.
13.
Denham, James W., Mahesh Kumar, David S. Lamb, et al.. (2009). Recognizing False Biochemical Failure Calls After Radiation With or Without Neo-Adjuvant Androgen Deprivation for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(2). 404–411.
14.
Capp, Anne, Mario Inostroza-Ponta, Pablo Moscato, et al.. (2008). Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial. Radiotherapy and Oncology. 90(3). 400–407.
15.
Denham, James W., Allison Steigler, David S. Lamb, et al.. (2008). Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial. The Lancet Oncology. 9(11). 1058–1068.
16.
Denham, James W., David S. Lamb, David Joseph, et al.. (2008). PSA response signatures – a powerful new prognostic indicator after radiation for prostate cancer?. Radiotherapy and Oncology. 90(3). 382–388.
17.
Lamb, David S., James W. Denham, Hedy Mameghan, et al.. (2003). Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer. Radiotherapy and Oncology. 68(3). 255–267.
18.
Collier, Christine, et al.. (1994). Monitoring of monoclonal gammopathies: Rational use of densitometry and rate nephelometry. Clinical Biochemistry. 27(6). 457–461.
19.
McDonald, Kenneth, Gary S. Francis, John Matthews, David Hunter, & Jay N. Cohn. (1993). Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. Journal of the American College of Cardiology. 21(2). 514–522.
20.
McDonald, Kenneth, Gary S. Francis, Peter F. Carlyle, et al.. (1992). Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog. Journal of the American College of Cardiology. 19(2). 460–467.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sharon Salenius Breakdown of academic impact, for papers by Keen‐Hun Tai Breakdown of academic impact, for papers by David S. Lamb Breakdown of academic impact, for papers by Michelle H. Braccioforte Breakdown of academic impact, for papers by Allison Steigler Breakdown of academic impact, for papers by Phillip Rubin Breakdown of academic impact, for papers by Chris Atkinson Breakdown of academic impact, for papers by S. Guérif Breakdown of academic impact, for papers by Friedl Vanhaverbeke Breakdown of academic impact, for papers by Julie Butters